As health systems are set to start reporting their third quarter earnings results this week, new research highlights hospitals’ ongoing fears about financial viability, patient volumes and supply stocks. That’s as new hotspots in the Midwest report rising COVID-19 case loads and hospitals prepare for the pandemic to collide with flu season, potentially causing stress… Read More »
Everything You HAVE TO KNOW about Dangerous Genetically Modified Foods from Jeffrey Smith on Vimeo. A study demonstrates the toxicity of three genetically modified corn varieties from the American seed company Monsanto, according to the Committee for Independent Research and Information on Genetic Engineering. “For the first time in the world, we’ve proven that GMO… Read More »
The Division of Clinical Psychology of the British Psychological Society issued a book-length report called Understanding Psychosis and Schizophrenia, edited by Anne Cooke and with contributions by service providers and service users. I highly recommend it to you. In it the contributors take a fresh look at “psychosis” and “schizophrenia,” consistently distinguish between a phenomenon (like hearing voices)… Read More »
By BRIAN KLEPPER and JEFFREY HOGAN GoodRx’s planned initial public offering recently made the news, notable because the company, launched in 2011, has been profitable since 2016. Evidently, it’s become unfashionable for investors to demand proof of performance, so GoodRx’s results shone like a beacon. By contrast, most health care firms seeking funding convey bold… Read More »